Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
Shattuck Labs, Inc.
Shattuck Labs, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
NextCure, Inc.
Bristol-Myers Squibb
Amgen
American Regent, Inc.
Celgene
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
BerGenBio ASA
Takeda
Amgen
Kyowa Kirin Co., Ltd.
Pfizer
Takeda
Amgen
Karyopharm Therapeutics Inc
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Novartis
Daiichi Sankyo
Bristol-Myers Squibb
University of Florida
Eli Lilly and Company
Boehringer Ingelheim
Stanford University
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Otsuka Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Icahn School of Medicine at Mount Sinai
Eisai Inc.